关注
Mona Alshahawey
Mona Alshahawey
Assistant Professor of Clinical Pharmacy Ain Shams University
在 pharm.asu.edu.eg 的电子邮件经过验证
标题
引用次数
引用次数
年份
Effect of febuxostat on the endothelial dysfunction in hemodialysis patients: a randomized, placebo-controlled, double-blinded study
M Alshahawey, SM Shahin, TW Elsaid, NA Sabri
American Journal of Nephrology 45 (5), 452-459, 2017
322017
Sex-mediated effects of ACE2 and TMPRSS2 on the incidence and severity of COVID-19; the need for genetic implementation
M Alshahawey, M Raslan, N Sabri
Current research in translational medicine 68 (4), 149, 2020
272020
A genetic insight into vitamin D binding protein and COVID-19
M Alshahawey
Medical Hypotheses 149, 110531, 2021
212021
Effect of febuxostat on oxidative stress in hemodialysis patients with endothelial dysfunction: A randomized, placebo-controlled, double-blinded study
M Alshahawey, SM Shaheen, T Elsaid, NA Sabri
International Urology and Nephrology 51, 1649-1657, 2019
182019
The impact of cholecalciferol on markers of vascular calcification in hemodialysis patients: A randomized placebo controlled study
M Alshahawey, R Elborolossy, L El Wakeel, T Elsaid, NA Sabri
Nutrition, Metabolism and Cardiovascular Diseases 31 (2), 626-633, 2021
172021
New insights on mucormycosis and its association with the COVID-19 pandemic
ME Mona Alshahawey, Ghadir Elhossainey, Noha Salah, Lamia Elwakeel, Khaled ...
Future Science OA, 18, 2021
14*2021
COVID-19 and Vitamin D deficiency; the two pandemics. Are they correlated
M Alshahawey
Int J Vitam Nutr Res 91 (5-6), 383-384, 2021
92021
Does human leukocyte antigen gene polymorphism affect management of COVID-19 Patients
MA Raslan, M Alshahawey, EM Shehata, NA Sabri
A review article. Scientific J Genet Gene Ther 6 (1), 001-003, 2020
62020
Management protocols for COVID-19: Will it include targeting ADAM 17
NA Sabri, MA Raslan, M Alshahawey, E Shehata
Allied J Med Res 2020; 4 (1): 5฀-54. 54 Allied J Med Res 2020 Volume 4 …, 2020
22020
COVID-19 and Antiviral Therapies in Cancer Patients-will it Make Difference
M Alshahawey, MA Raslan, NA Sabri
Ann Hematol Oncol Res 1 (2), 1008, 2020
22020
Characterizing apparent treatment resistant hypertension in the United States: insights from the All of Us Research Program
M Alshahawey, E Jafari, SM Smith, CW McDonough
Journal of the American Medical Informatics Association 31 (12), 2899-2907, 2024
12024
Association of COVID-19 with genotyping ApoEe4 and APOBEC3B
NA Sabri, MA Raslan, M Alshahawey
Allied J Med Res 2020; 4 (1):฀฀-฀ 6. 6 Allied J Med Res 2020 Volume 4 …, 2020
12020
Cost-effectiveness analysis of denosumab versus alendronate for improving bone mineral density in renal transplant recipients: a comparative study
M Alshahawey, MA Shawki, SA Sayed, A Elseasi, L ElWakeel
Future Journal of Pharmaceutical Sciences 10 (1), 146, 2024
2024
Cholecalciferol effect on oxidative stress and novel predictors of inflammation in hemodialysis patients: a prospective randomized trial
M Alshahawey, LM El Wakeel, TW Elsaid, NA Sabri, RM Elborolossy
Future Journal of Pharmaceutical Sciences 10 (1), 121, 2024
2024
Optimal hyperglycemia thresholds in patients undergoing chemotherapy: a cross sectional study of oncologists’ practices
TM Salgado, PB Birari, M Alshahawey, E Hickey Zacholski, E Mackler, ...
Supportive Care in Cancer 32 (8), 563, 2024
2024
Cost-effectiveness analysis of once-weekly semaglutide vs. once-daily liraglutide administered subcutaneously in patients with overweight and obesity: a decision analysis.
M Alshahawey, M Ghazy, M El Morshedy, NO El Said
European Review for Medical & Pharmacological Sciences 28 (9), 2024
2024
# 3706 EFFECT OF CHOLECALCIFEROL INTAKE ON NOVEL INFLAMMATORY INDICATORS IN HEMODIALYSIS PATIENTS
MA Ghazy, L Elwakeel, N Sabri, TE Said, R Maher
Nephrology Dialysis Transplantation 38 (Supplement_1), gfad063c_3706, 2023
2023
The use of Nicotinamide in Parkinson’s disease; A Possible path to the future. Review Article
SF Fahmy, M Alshahawy, N Mohamed, N Gamal, S Abdelazim, ...
Archives of Pharmaceutical Sciences Ain Shams University 7 (1), 147-170, 2023
2023
WEEKLY VERSUS MONTHLY ORAL CHOLECALCIFEROL ON OXIDATIVE STRESS AND INFLAMMATORY MARKERS IN HEMODIALYSIS PATIENTS: A PROSPECTIVE RANDOMIZED TRIAL.
M Alshahawey, L ElWakeel, T El Said, N Sabri
NEPHROLOGY DIALYSIS TRANSPLANTATION 35, 1891-1891, 2020
2020
P1571 WEEKLY VERSUS MONTHLY ORAL CHOLECALCIFEROL ON OXIDATIVE STRESS AND INFLAMMATORY MARKERS IN HEMODIALYSIS PATIENTS: A PROSPECTIVE RANDOMIZED TRIAL.
M Alshahawey, L ElWakeel, T El Said, N Sabri
Nephrology Dialysis Transplantation, Volume 35, Issue Supplement_3, June …, 2020
2020
系统目前无法执行此操作,请稍后再试。
文章 1–20